Utah Medical Products (UTMD) Liabilities and Shareholders Equity (2016 - 2025)
Historic Liabilities and Shareholders Equity for Utah Medical Products (UTMD) over the last 16 years, with Q3 2025 value amounting to $122.0 million.
- Utah Medical Products' Liabilities and Shareholders Equity fell 595.17% to $122.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $487.8 million, marking a year-over-year decrease of 806.43%. This contributed to the annual value of $122.5 million for FY2024, which is 953.8% down from last year.
- Latest data reveals that Utah Medical Products reported Liabilities and Shareholders Equity of $122.0 million as of Q3 2025, which was down 595.17% from $120.8 million recorded in Q2 2025.
- Utah Medical Products' 5-year Liabilities and Shareholders Equity high stood at $135.5 million for Q4 2023, and its period low was $114.4 million during Q1 2021.
- Moreover, its 5-year median value for Liabilities and Shareholders Equity was $122.5 million (2025), whereas its average is $123.8 million.
- In the last 5 years, Utah Medical Products' Liabilities and Shareholders Equity surged by 1279.54% in 2021 and then tumbled by 954.07% in 2025.
- Utah Medical Products' Liabilities and Shareholders Equity (Quarter) stood at $115.6 million in 2021, then rose by 7.12% to $123.9 million in 2022, then grew by 9.35% to $135.5 million in 2023, then fell by 9.54% to $122.5 million in 2024, then fell by 0.46% to $122.0 million in 2025.
- Its last three reported values are $122.0 million in Q3 2025, $120.8 million for Q2 2025, and $122.5 million during Q1 2025.